2023 annual financial data
Neurocrine Biosciences 2023 Operating margin
Neurocrine Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was 13.3%.
Operating income was 250,900,000 USD and net income was 249,700,000 USD.
Operating cash flow was 389,900,000 USD.
Get free Neurocrine Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,887,100,000 USD
- Operating income
- 250,900,000 USD
- Net income
- 249,700,000 USD
- Operating cash flow
- 389,900,000 USD